Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

ROSWELL PARK CANCER INSTITUTE

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma

Phase 1

Completed

Conditions: Lung Cancer
Malignant Mesothelioma

First Posted Date: 2004-08-20

Last Posted Date: 2011-03-07

Lead Sponsor: Roswell Park Cancer Institute

Target Recruit Count: 20

Registration Number: NCT00003974

Locations: 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States

Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer

Phase 1

Completed

Conditions: Leukemia
Lymphoma
Unspecified Adult Solid Tumor, Protocol Specific

First Posted Date: 2004-08-13

Last Posted Date: 2011-03-07

Lead Sponsor: Roswell Park Cancer Institute

Target Recruit Count: 24

Registration Number: NCT00003294

Locations: 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States

Epidural Hydromorphone Compared With Hydromorphone Infusion in Treating Patients With Prostate Cancer Undergoing Radical Prostatectomy

Phase 3

Completed

Conditions: Prostate Cancer
Pain

First Posted Date: 2004-08-12

Last Posted Date: 2011-02-23

Lead Sponsor: Roswell Park Cancer Institute

Target Recruit Count: 40

Registration Number: NCT00003115

Locations: 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States

Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer

Phase 2

Completed

Conditions: Graft Versus Host Disease
Leukemia
Lymphoma
Myelodysplastic Syndromes
Neuroblastoma

First Posted Date: 2004-08-04

Last Posted Date: 2011-03-07

Lead Sponsor: Roswell Park Cancer Institute

Target Recruit Count: 3

Registration Number: NCT00003661

Locations: 🇺🇸
University of Florida Health Science Center, Gainesville, Florida, United States
🇺🇸
Division of Pediatric Surgery, Jacksonville, Florida, United States
🇺🇸
Nemours Children's Clinic, Jacksonville, Florida, United States

and more 14 locations

Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases

Phase 2

Completed

Conditions: Graft Versus Host Disease
Leukemia
Myelodysplastic Syndromes
Thymic Carcinoma

First Posted Date: 2004-08-04

Last Posted Date: 2011-03-07

Lead Sponsor: Roswell Park Cancer Institute

Target Recruit Count: 90

Registration Number: NCT00003662

Locations: 🇺🇸
University of Florida Health Science Center, Gainesville, Florida, United States
🇺🇸
Division of Pediatric Surgery, Jacksonville, Florida, United States
🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

and more 12 locations

Morphine for the Treatment of Pain in Patients With Breast Cancer

Completed

Conditions: Pain

First Posted Date: 2004-07-30

Last Posted Date: 2015-10-14

Lead Sponsor: Roswell Park Cancer Institute

Target Recruit Count: 18

Registration Number: NCT00003000

Locations: 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States

Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer

Phase 1

Completed

Conditions: Breast Cancer

First Posted Date: 2004-07-16

Last Posted Date: 2011-03-07

Lead Sponsor: Roswell Park Cancer Institute

Target Recruit Count: 30

Registration Number: NCT00003877

Locations: 🇺🇸
Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States
🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
🇺🇸
Ireland Cancer Center, Cleveland, Ohio, United States

Capecitabine, Oxaliplatin, and Gefitinib in Treating Patients With Metastatic Colorectal Cancer

Phase 1

Terminated

Conditions: Colorectal Cancer

First Posted Date: 2004-07-12

Last Posted Date: 2013-02-01

Lead Sponsor: Roswell Park Cancer Institute

Target Recruit Count: 10

Registration Number: NCT00087334

Locations: 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States

Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Rectum

Phase 1

Completed

Conditions: Colorectal Cancer

First Posted Date: 2004-07-12

Last Posted Date: 2013-03-08

Lead Sponsor: Roswell Park Cancer Institute

Target Recruit Count: 37

Registration Number: NCT00086931

Locations: 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States

Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant

Phase 2

Completed

Conditions: Graft Versus Host Disease
Unspecified Adult Solid Tumor, Protocol Specific
Unspecified Childhood Solid Tumor, Protocol Specific

First Posted Date: 2004-06-17

Last Posted Date: 2011-03-07

Lead Sponsor: Roswell Park Cancer Institute

Target Recruit Count: 36

Registration Number: NCT00003894

Locations: 🇺🇸
Arkansas Children's Hospital, Little Rock, Arkansas, United States
🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States
🇺🇸
Louisiana State University School of Medicine, New Orleans, Louisiana, United States

and more 7 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy